IDH1R132H peptide vaccine (German Cancer Research Center)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIDH1R132H peptide vaccine (German Cancer Research Center)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesGerman Cancer Research Center (Dkfz)
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A